Fujifilm to buy Biogen Danish subsidiary for $890 million
It said it expects the acquisition of Biogen Denmark Manufacturing ApS to be completed in August.
The Denmark unit has a facility equipped with six 15,000 liter bioreactors that can manufacture cell culture-derived biologics.
Biogen said it expects the site’s 800 staff to remain employed.
Through the acquisition, Fujifilm aims to achieve its 100 billion yen ($897.91 million) revenue target in its contact development and manufacturing organization (CDMO) business by 2021, two years ahead of its original goal. ■